Prolor Biotech (PBTH) +8.3% premarket after receiving a notice of allowance from the U.S. patent...


Prolor Biotech (PBTH) +8.3% premarket after receiving a notice of allowance from the U.S. patent office for a new patent application covering its long-acting CTP-enhanced human growth hormone. The patent gives PBTH additional intellectual property protection covering methods for the induction of growth in growth hormone deficient patients.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs